Acquired angioedema and rituximab-induced acute thrombocytopenia in splenic marginal zone lymphoma

Acquired angioedema and rituximab-induced acute thrombocytopenia in splenic marginal zone lymphoma

Saved in:

Bibliographic Details
Main Authors:	Odd Terje Brustugun, Erik Waage Nielsen
Format:	Article
Language:	English
Published:	Medical Journals Sweden 2025-07-01
Series:	Acta Oncologica
Subjects:	lymphoma angioedema rituximab thrombocytopenia rituximab-induced acute thrombocytopenia
Online Access:	https://medicaljournalssweden.se/actaoncologica/article/view/43897
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Secondary Thrombocytopenia with Primary Sjogren's Syndrome: A Rare Presentation
by: Sanchu T. K. Sreeraj, et al.
Published: (2021-07-01)

Rituximab in the treatment of nodal Bcell marginal zone lymphoma, primary Sjogren’s syndrome and autoimmune hepatitis
by: O A Logvinenko, et al.
Published: (2008-10-01)

BENDAMUSTINE AND RITUXIMAB AS FIRST LINE TREATMENT IN SPLENIC MARGINAL ZONE LYMPHOMAS of ELDERLY PATIENTS.
by: Roberto Castelli
Published: (2016-07-01)

Cost-per-responder analysis for eltrombopag and rituximab in the treatment of primary immune thrombocytopenia in Spain
by: Eduardo Anguita, et al.
Published: (2020-11-01)

Symptomatic Follicular Lymphoma: Complete Remission After Chemoimmunotherapy with Bendamustine–Rituximab
by: Wulyo Rajabto, et al.
Published: (2024-07-01)

The efficacy of therapy with rituximab (R-CHOP) in patients with diffuse large cells lymphoma
by: T. D. Lutskaya, et al.
Published: (2014-07-01)

A case of primary ovarian lymphoma with autoimmune hemolytic anemia achieving complete response with Rituximab-based combination chemotherapy
by: N S Ghadyalpatil, et al.
Published: (2011-01-01)

Corticosteroid-dependent chronic immune thrombocytopenic purpura in an 11-year-old child responsive to low-dose rituximab: a case report
by: Zainab Omar, et al.
Published: (2025-06-01)

Rituximab in pediatric B-cell Non-Hodgkin Lymphoma: Clinical outcomes and prognostic implications
by: Şefika Akyol, et al.
Published: (2025-03-01)

Research progress in the treatment of chronic primary immune thrombocytopenia
by: HUANG Zhouxuan, et al.
Published: (2025-04-01)

Efficacy and safety of rituximab-based chemoimmunotherapy in adult patients with Burkitt lymphoma in Korea
by: Gi-June Min, et al.
Published: (2025-07-01)

Experience of using rituximab for recurrent non-Hodgkin lymphoma in elderly patients of the Orel region
by: R. A. Golubenko, et al.
Published: (2014-07-01)

The effectiveness of rituximab and HIV on the survival of Ontario patients with diffuse large B‐cell lymphoma
by: Steven Habbous, et al.
Published: (2020-10-01)

Loss of CD20 Expression in Follicular Lymphoma after Program Anti-Tumor Therapy Including Rituximab: Literature Data and Case Report
by: OM Volodina, et al.
Published: (2017-04-01)

Combined chemoimmunotherapy of patients with mature B-cell non-Hodgkin lymphomas age group until 18 years: results of multicenter study NHL 2004 m with rituximab and modified B-NHL BFM 90 protocol applications
by: E. V. Samochatova, et al.
Published: (2022-11-01)

Acquired Hemophilia A successfully treated with rituximab
by: Giovanni D'Arena, et al.
Published: (2015-02-01)

Use of rituximab in mature, high-grade and advanced-stage pediatric B-lineage non-Hodgkin lymphomas: a systematic review, meta-analysis and the Brazilian reality
by: Alejandra Adriana Cardoso de Castro, et al.
Published: (2025-01-01)

Evaluation of effectiveness of long-term therapy with Russian rituximab biosimilar in Sjogren’s disease in real clinical practice
by: B. D. Chaltsev, et al.
Published: (2025-07-01)

A randomized, multiple-dose, multicenter, comparative parallel study to evaluate the safety and efficacy of intravenous infusion of rituximab (Hetero) and reference medicinal product (Rituximab, Roche) in Indian patients of non-hodgkin's lymphoma (HERILY)
by: Suresh Advani, et al.
Published: (2018-01-01)

Investigating thrombocytopenia in Meropenem-treated patients: a cross-sectional observational study
by: Ahmed E. Altyar, et al.
Published: (2025-07-01)

Clinical and Laboratory Analysis of Children Who Follow Up with Thrombocytopenia: A Retrospective Study
by: Yasemin Denkboy Öngen, et al.
Published: (2025-04-01)

Lymphomatoid Granulomatosis of Central Nervous System and Lung Driven by Epstein Barr Virus Proliferation: Successful Treatment with Rituximab
by: Ruben Fernandez, et al.
Published: (2014-02-01)

Primary renal mucosa-associated lymphoid tissue lymphoma coexisting with immune thrombocytopenia
by: Jiatai He, et al.
Published: (2025-07-01)

A case of angioimmunoblastic T-cell lymphoma mimicking angioedema
by: He Zhao, et al.
Published: (2025-06-01)

Obinutuzumab-induced severe acute thrombocytopenia: a case report and literature review
by: Kun Kou, et al.
Published: (2025-08-01)

Association of rituximab use with adverse events in adults with lymphoma or autoimmune disease: a single center experience
by: Mengsi Hu, et al.
Published: (2025-04-01)

Angioedema
by: Gina Lacuesta, et al.
Published: (2024-12-01)

Single-agent rituximab and ultra-low-dose adaptive radiotherapy for the treatment of indolent B-cell non-Hodgkin lymphomas
by: Katherine E. Lake, et al.
Published: (2025-07-01)

Glomerulonephritis associated with marginal zone B-cell lymphoma: clinical, pathological characteristics of renal injury and treatment (clinical cases)
by: B. T. Dzhumabaeva, et al.
Published: (2015-12-01)

Research Progress of Pulmonary Extranodal Marginal Zone Lymphoma
by: Shaowei ZHANG
Published: (2024-12-01)

Use of rituximab in systemic lupus erythematosus in children: a review
by: A. N. Arefyeva
Published: (2019-11-01)

EXPERIENCE WITH RITUXIMAB IN PATIENTS WITH ANKYLOSING SPONDYLITIS
by: Mikhail Sergeyevich Protopopov, et al.
Published: (2013-02-01)

USE OF RITUXIMAB IN PATIENTS WITH LUPUS NEPHRITIS
by: Anna Vasilyevna Torgashina, et al.
Published: (2010-08-01)

Concurrent type 1 diabetes mellitus and beta-cell lymphoma in a 12 year-old child: treatment with rituximab does not changethe clinical course of diabetes
by: Aleksey Vasil'evich Kiyaev, et al.
Published: (2009-09-01)

Trends in survival of patients with stage I/II Burkitt lymphoma in the United States: A SEER database analysis
by: Ze‐Long Liu, et al.
Published: (2019-03-01)

Thrombocytopenia following kidney transplantation: a frequent, underestimated and potentially severe complication
by: Cédric Léonard, et al.
Published: (2025-03-01)

Platelet parameters for distinguishing between inherited macrothrombocytopenia and acquired thrombocytopenia: a retrospective case–control study
by: Wenlan Chen, et al.
Published: (2025-12-01)

Potential of anticoagulant therapy in cardiology practice for thrombocytopenia. Literature review
by: K. G. Pereverzeva, et al.
Published: (2023-09-01)

Prediction of hereditary angioedema during attacks in patients with recurrent angioedema: Awareness at a glance with the hereditary angioedema prediction score
by: Semra Demir, et al.
Published: (2025-04-01)

Dynamics of the level of calprotectin in patients with rheumatoid arthritis during rituximab biosimilar (Acellbia “Biocad”) therapy
by: A. S. Avdeeva, et al.
Published: (2021-09-01)